Generation of chimeric bispecific G250/anti-CD3 monoclonal antibody, a tool to combat renal cell carcinoma.

The monoclonal antibody (MAb) G250 binds to a tumour-associated antigen, expressed in renal cell carcinoma (RCC), which has been demonstrated to be a suitable target for antibody-mediated immunotherapy. A bispecific antibody having both G250 and anti-CD3 specificity can cross-link G250 antigen-expre...

Descripción completa

Detalles Bibliográficos
Autores principales: Luiten, R. M., Coney, L. R., Fleuren, G. J., Warnaar, S. O., Litvinov, S. V.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1996
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074712/
https://www.ncbi.nlm.nih.gov/pubmed/8795576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074712/
https://www.ncbi.nlm.nih.gov/pubmed/8795576

Ejemplares similares